Marsh & McLennan Companies, Inc. (MRSH) Stock Forecast
Data as of May 2, 2026Financial Services · Current price $166.55 (-0.69%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 17, 2026 | Strong Buy | Raymond James | $225.00 | +35.1% |
| Jan 13, 2026 | Elyse Greenspan | Wells Fargo | $199.00 | +19.5% |
| Jan 8, 2026 | Alex Scott | Barclays | $210.00 | +26.1% |
| Jan 7, 2026 | Robert Cox | Goldman Sachs | $199.00 | +19.5% |
| Dec 16, 2025 | Bob Huang | Morgan Stanley | $190.00 | +14.1% |
| Nov 20, 2025 | Alex Scott | Barclays | $206.00 | +23.7% |
| Oct 20, 2025 | Harry Fong | Roth Capital | $200.00 | +20.1% |
| Oct 17, 2025 | Elyse Greenspan | Wells Fargo | $212.00 | +27.3% |
| Oct 8, 2025 | Alex Scott | Barclays | $221.00 | +32.7% |
| Oct 7, 2025 | Bob Huang | Morgan Stanley | $215.00 | +29.1% |
| Aug 18, 2025 | Bob Huang | Morgan Stanley | $220.00 | +32.1% |
| Aug 12, 2025 | Ryan Tunis | Cantor Fitzgerald | $256.00 | +53.7% |
| Jul 21, 2025 | Brian Meredith | UBS | $258.00 | +54.9% |
| Oct 22, 2024 | Michael Zaremski | BMO Capital | $228.00 | +36.9% |
| Oct 18, 2024 | Harry Fong | Roth Capital | $230.00 | +38.1% |
| Oct 18, 2024 | Mark Dwelle | RBC Capital | $242.00 | +45.3% |
| Oct 18, 2024 | Robert Cox | Goldman Sachs | $220.00 | +32.1% |
| Oct 10, 2024 | Joshua Shanker | Bank of America Securities | $250.00 | +50.1% |
| Oct 1, 2024 | Michael Zaremski | BMO Capital | $217.00 | +30.3% |
| Sep 4, 2024 | Alex Scott | Barclays | $236.00 | +41.7% |
Top Analysts Covering MRSH
MRSH vs Sector & Market
| Metric | MRSH | Financial Services Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.67 | 2.51 | 2.41 |
| Analyst Count | 27 | 8 | 18 |
| Target Upside | +24.4% | +64.8% | +14.9% |
| P/E Ratio | 20.82 | -5.02 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $28.17B | $28.40B | $28.61B | 13 |
| 2027-03-31 | $7.74B | $7.92B | $7.99B | 4 |
| 2027-06-30 | $7.48B | $7.66B | $7.73B | 4 |
| 2027-09-30 | $6.80B | $6.96B | $7.03B | 5 |
| 2027-12-31 | $7.08B | $7.25B | $7.32B | 4 |
| 2028-03-31 | $8.15B | $8.35B | $8.42B | 3 |
| 2028-06-30 | $7.83B | $8.01B | $8.09B | 3 |
| 2028-09-30 | $7.13B | $7.30B | $7.37B | 5 |
| 2028-12-31 | $7.40B | $7.58B | $7.65B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $10.27 | $10.40 | $10.55 | 14 |
| 2027-03-31 | $3.45 | $3.56 | $3.60 | 10 |
| 2027-06-30 | $3.09 | $3.19 | $3.22 | 6 |
| 2027-09-30 | $2.10 | $2.17 | $2.20 | 7 |
| 2027-12-31 | $2.34 | $2.42 | $2.45 | 6 |
| 2028-03-31 | $3.76 | $3.88 | $3.92 | 7 |
| 2028-06-30 | $3.39 | $3.50 | $3.54 | 7 |
| 2028-09-30 | $2.31 | $2.38 | $2.41 | 12 |
| 2028-12-31 | $2.57 | $2.65 | $2.68 | 7 |
Frequently Asked Questions
What is the analyst consensus for MRSH?
The consensus among 27 analysts covering Marsh & McLennan Companies, Inc. (MRSH) is Hold with an average price target of $212.82.
What is the highest price target for MRSH?
The highest price target for MRSH is $258.00, set by Brian Meredith at UBS on 2025-07-21.
What is the lowest price target for MRSH?
The lowest price target for MRSH is $135.00, set by Phil Stefano at Deutsche Bank on 2021-04-28.
How many analysts cover MRSH?
27 analysts have issued ratings for Marsh & McLennan Companies, Inc. in the past 12 months.
Is MRSH a buy or sell right now?
Based on 27 analyst ratings, MRSH has a consensus rating of Hold (2.67/5) with a +24.4% upside to the consensus target of $212.82.
What are the earnings estimates for MRSH?
Analysts estimate MRSH will report EPS of $10.40 for the period ending 2026-12-31, with revenue estimated at $28.40B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.